| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |